Editorial Comment from Dr Yuasa to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
- PMID: 32914081
- PMCID: PMC7469836
- DOI: 10.1002/iju5.12199
Editorial Comment from Dr Yuasa to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int. J. Radiat. Oncol. Biol. Phys. 1996; 34: 251–66. - PubMed
-
- Hammers HJ, Vonmerveldt D, Ahn C et al Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC). 2020 Genitourinary Cancers Symposium; 15 Feb 2020.. [Cited 24 Feb 2020]. Available from URL: https://meetinglibrary.asco.org/record/183203/abstract